Initial response to portoenterostomy determines long-term outcome in patients with biliary atresia.
OBJECTIVE
The aim of this study was to assess the efficacy of portoenterostomy in biliary atresia and determine factors that predict outcomes.


METHODS
The outcomes after portoenterostomy for biliary atresia from 1976 to 1996 were graded into 3 defined groups: G (good, jaundice free); I (intermediate, progressive liver disease with liver transplant if needed after 3 years of age); P (poor, liver transplant or death at less than 3 years of age).


RESULTS
Twenty-seven of 49 children (55%) who underwent portoenterostomy responded. Of these, 13 (26%) were jaundice free (G). Of 14 children (28%) in I, 6 underwent liver transplant after 3 years of age. Of 22 children (44.8%) in P, 14 (28%) died before 3 years and 8 underwent liver transplant before 3 years. Thus, 42% of the children in this series are surviving with native liver. Age at operation in P was significantly different compared with G. Preoperative values of bilirubin and alanine transaminase were comparable in the 3 groups. Postoperative values of bilirubin and alanine transaminase were lower in G and I compared with P Complications were significantly lower in group G.


CONCLUSIONS
Portoenterostomy alone in biliary atresia is beneficial in 40% of cases. Factors associated with the outcome include age at operation, postoperative cholangitis, and change in values of bilirubin and alanine transaminase. A classification based on decline of bilirubin and enzyme levels 3 months after portoenterostomy is proposed to predict the long-term outcome of an individual case of biliary atresia. It is particularly relevant in the intermediate group in which timing of referral may preclude or compromise liver transplant.
Subramaniam
R
R
Department of Paediatric Surgery, Booth Hall Children's Hospital, Blackley, Manchester, England.
Doig
C M
CM
Bowen
J
J
Bruce
J
J
D000410:Alanine Transaminase / Q000097:blood; D001656:Biliary Atresia / Q000097:blood / Q000601:surgery*; D002648:Child; D006801:Humans; D016031:Liver Transplantation; D011171:Portoenterostomy, Hepatic; D016896:Treatment Outcome
D000410:Alanine Transaminase